HYDRIX Trademark

Trademark Overview

On Wednesday, February 22, 2023, a trademark application was filed for HYDRIX with the United States Patent and Trademark Office. The USPTO has given the HYDRIX trademark a serial number of 97807095. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, April 29, 2025. This trademark is owned by Caldera Medical, Inc.. The HYDRIX trademark is filed in the Pharmaceutical Products category with the following description:

Biologic Implants, namely, allograft and xenograft biological tissue intended for subsequent implantation
hydrix

General Information

Serial Number97807095
Word MarkHYDRIX
Filing DateWednesday, February 22, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, April 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2024

Trademark Statements

Goods and ServicesBiologic Implants, namely, allograft and xenograft biological tissue intended for subsequent implantation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCaldera Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91361
Party NameCaldera Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAgoura Hills, CA 91301

Trademark Events

Event DateEvent Description
Monday, November 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, February 25, 2023NEW APPLICATION ENTERED
Monday, March 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 20, 2023ASSIGNED TO EXAMINER
Monday, November 20, 2023NON-FINAL ACTION WRITTEN
Monday, November 20, 2023NON-FINAL ACTION E-MAILED
Wednesday, January 24, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 24, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, January 24, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 25, 2024ASSIGNED TO LIE
Thursday, January 25, 2024EXAMINER'S AMENDMENT ENTERED
Friday, January 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2024SOU EXTENSION 1 GRANTED
Tuesday, October 29, 2024SOU EXTENSION 1 FILED
Monday, December 2, 2024REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, April 28, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, April 29, 2025SOU EXTENSION 2 FILED
Tuesday, April 29, 2025SOU EXTENSION 2 GRANTED
Tuesday, April 29, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

hydrix tissue intended subsequent implantation biological xenograft implants namely allograft biologic